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Copyright © 2005 by The American Asso-
ciation for Thoracic Surgerydoi:10.1016/j.jtcvs.2004.10.006Objective: Hypothermic cardiopulmonary bypass is associated with increased fluid
extravasation. This study aimed to compare whether iso-oncotic priming solutions,
in contrast to crystalloids, could reduce the cold-induced fluid extravasation during
cardiopulmonary bypass in piglets.
Methods: Three groups were studied: the control group (CT group; n  10), the
albumin group (Alb group; n  7), and the hydroxyethyl starch group (HES group;
n  7). Prime (1000 mL) and supplemental fluid were acetated Ringer solution, 4%
albumin, and 6% hydroxyethyl starch, respectively. After 1 hour of normothermic
cardiopulmonary bypass, hypothermic cardiopulmonary bypass (cooling to 28°C
within 15 minutes) was initiated and continued to 90 minutes. Fluid needs, plasma
volume, changes in colloid osmotic pressure in plasma and interstitial fluid, hemat-
ocrit levels, and tissue water content were recorded, and protein masses and fluid
extravasation rates were calculated.
Results: Colloid osmotic pressure in plasma decreased immediately after the start of
cardiopulmonary bypass in the CT group but remained stable in the Alb and HES
groups. Colloid osmotic pressure in interstitial fluid tended to decrease in the CT
group and remained unchanged in the Alb group, whereas a slight increase was
observed in the HES group. Immediately after the start of cooling, fluid extravasa-
tion rates increased from 0.15  0.10 to 0.64  0.12 mL · kg1 · min1 in the CT
group, whereas no such increase was observed in the Alb and HES groups. The
changes in fluid extravasation rates were reflected by corresponding changes in
tissue water content.
Conclusion: The use of albumin or hydroxyethyl starch as prime to preserve the
colloid osmotic pressure during cardiopulmonary bypass causes a reduction in the
cold-induced fluid extravasation compared with that seen with crystalloids. Albumin
seems more effective than hydroxyethyl starch to limit cold-induced fluid shifts
during cardiopulmonary bypass.
T he use of cardiopulmonary bypass (CPB) is associated with fluid accumu-lation and edema formation, occasionally causing organ dysfunction.1,2 Theheart, lungs, gastrointestinal tract, and central nervous system might be
affected. Together with hypothermia, hemodilution and a general inflammatory
The Journal of Thoracic and Cardiovascular Surgery ● Volume 130, Number 2 287
Cardiopulmonary Support and Physiology Farstad, Kvalheim, Husby
CSPresponse syndrome related to contact between blood and
tubing surface material have been held responsible.3,4
In a recent study we evaluated the effect of anti-inflamma-
tory agents on fluid homeostasis during normothermic and
hypothermic CPB. None of the drugs tested (methylpred-
nisolone, vitamin C, or -trinositol) revealed any effect on the
fluid leakage during CPB.5 In previous studies we found an
abrupt and persisting increase in fluid filtration from circulation
to the interstitial space after the start of cooling when acetated
Ringer solution was used as prime.6-8 In these studies the
colloid osmotic pressures (COP) in plasma remained low after
the initial hemodilution at the start of CPB.5-8
We hypothesized that preservation of an iso-oncotic
pressure in plasma could reduce or prevent the cold-induced
fluid extravasation from circulation to the interstitial space
during CPB. We designed our study to compare the effects
on microvascular fluid exchange of 3 different priming
solutions (pure crystalloid solution, albumin, and heta-
starch) in piglets undergoing normothermic and hypother-
mic CPB.
Materials and Methods
Animal Handling and Anesthesia
Thirty-seven domestic piglets (Norwegian Landrace Norhybrid;
Stend Agriculture College, Bergen, Norway) were studied. They
were about 12 weeks old, about 30 kg, and received humane care
in accordance with recommendations given by the Norwegian
State Commission for Laboratory Animals. Food was withdrawn
12 hours before the study. Water was provided at all times.
Twenty-four of the animals were instrumented and subjected to
150 minutes of CPB. In addition, a historic non-CPB control group
(n  13) was included.5 Premedication of the animals and induc-
tion and maintenance of anesthesia were carried out according to
Figure 1. Albumin mass in the respective groups at the start of
and during bypass. Dotted line, Start of hypothermic CPB. Values
are presented as means  SEM. *P < .05 (calculated albumin
mass after 30 minutes of CPB compared with initial value).the methods of Farstad,5 Husby,9 and their associates.
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circulation was done after intravenous administration of heparin
(6 mg/kg body weight plus 3 mg/kg after 1 hour). In parallel,
arterial and venous lines for continuous monitoring of systemic
mean arterial pressure (MAP) and central venous pressure (CVP)
were placed in the left femoral artery and vein, respectively. A
urinary bladder catheter was inserted through a midline lapa-
ratomy. Surgical intervention was normally completed within 20
minutes. All animals were thereafter allowed 60 minutes’ stabili-
zation before the start of CPB.
CPB
Cannulation for CPB was established in the ascending aorta and
the right atrium, as recently presented.5 Pump flow was nonpul-
satile and set to 2.7 L · m2 · min1. During CPB, 0.5% isoflurane
was added to the machine oxygenator. Throughout the experi-
ments, there was a constant fixed height difference (73  3 cm)
between the level of the machine reservoir and the site of venous
drainage (the right atrium). Free venous drainage was controlled
continuously.
Study Design and Groups
Three groups were studied: the control group (CT group;
n  10), the albumin group (Alb group; n  7), and the hydroxy-
ethyl starch group (HES group; n  7). In addition, a non-CPB
control group (n  13) was included as a baseline for determina-
tion of total tissue water (TTW) content in the different study
groups.5
In the CT group the CPB circuit was primed with acetated
Ringer solution, and when needed, acetated Ringer solution was
added to the machine reservoir. Blood loss was substituted for
using Ringer solution in volumes of 3 times the blood loss volume.
During CPB, blood loss into the open chest was returned to
circulation through the extracorporeal machine reservoir.
In the Alb group the CPB circuit was primed with 4% albumin
(batch no. 027006610/N; osmolality, 278 mOsm/kg; Octapharma
AG, Vienna, Austria), and when needed, albumin was added to the
reservoir. Blood losses were corrected by means of intravenous
administration of 4% albumin in a 1:1 ratio.
In the HES group poly(O-2-hydroxyethyl) starch, 60 mg/mL
(HES 200/05; batch no. NF 8501/07; osmolarity, 308 mOsm/L;
Fresenius Kabi AB, Uppsala, Sweden), was mixed with acetated
Ringer solution to obtain a COP equivalent to the in vivo plasma
COP in each animal. This mixture was subsequently used for
priming of the CPB circuit, for fluid additions to the machine
reservoir when needed, and to substitute for blood loses in a 1:1
ratio. In all 3 groups, 5 mL/kg body weight per hour of acetated
Ringer solution was administered as maintenance fluid throughout
the experiments.
The priming volume of the CPB circuit was 1000 mL of fluid
in all groups, which regularly resulted in a filling of the machine
reservoir to the 400-mL level. This level was used as a fluid gauge.
Changes in this level indicated losses or gain of fluid from circu-
lation to the interstitial space or changes in vascular tone. When
the reservoir blood level decreased, fluid was supplied to restore
the 400-mL level.After stabilization for 60 minutes, normothermic CPB (38°C-
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P39°C) was initiated and continued for 60 minutes followed by 90
minutes of hypothermic CPB (28°C). By setting the water tem-
perature of the CPB heat exchanger to 5°C, a decrease in the core
temperature from 39°C to 28°C was achieved within 15 to 20
minutes. During CPB, nasopharyngeal and rectal temperatures
were measured continuously.
Hemodynamic Variables and Blood Analysis
Heart rate, MAP, CVP, hematocrit (Hct) level, plasma colloid
osmotic pressure (COPp), and serum concentrations of albumin,
total protein, and electrolytes, as well as acid-base parameters,
TABLE 1. Osmolality, mean arterial pressure, hematocrit
protein mass, fluid additions, diuresis, blood loss, and pla
Parameters Group
Before bypass Nor
0 min 5 min
Osmolality (mOsm/kg) CT 283.7 (1.7) 286
Alb 279.0 (1.8) 282
HES 290.3 (2.7)# 296
MAP (mm Hg) CT 49 (2.8)
Alb 50 (2.8)
HES 52 (2.5)
Hematocrit (%) CT 30 (0.8) 22 (0.6)†
Alb 30 (0.7) 23 (1.1)†
HES 29 (1.3) 18 (0.9)
Serum albumin (g/L) CT 28.4 (0.9) 23
Alb 33.0 (0.9) 35
HES 29.0 (1.4) 17
Serum total protein (g/L) CT 44.4 (1.2) 35
Alb 46.9 (1.1) 45
HES 46.3 (2.0) 27
Serum protein mass (g) CT 78.5 (3.7) 76
Alb 93.7 (9.3) 119
HES 74.5 (5.6) 75
Fluid additions (mL ·
kg1 · min1)
CT 0.
Alb 0.
HES 0.
Diuresis (mL · kg1 ·
min1)
CT 0.02 (0.01) 0.
Alb 0.02 (0.01) 0.
HES 0.03 (0.01) 0.
Blood loss (mL) CT 4
Alb 17
HES 8
Plasma volume (mL/kg) CT 55.8 (3.8) 46
Alb 56.5 (3.9) 48
HES 56.4 (3.1) 60
Values for diuresis and additions refer to the last 30 minutes. The values are
CT, control group (n  10); Alb, albumin group (n  7); HES, hydroxyethyl
§P  .01, and P  .001 compared with control value at same time. ¶P  .
the Alb group at same time. ††n  3. ‡‡P  .05 and §§P  .001 comparwere recorded as recently described.5
The Journal of ThoraciCOP and Plasma Volume Determination
COP was measured as previously described5 in plasma and inter-
stitial fluid, with a specially designed colloid osmometer accepting
sample volumes of 5 L.10 Fluid for determination of interstitial
colloid osmotic pressure (COPi) was sampled by using multifila-
mentous nylon wicks.11 Wick fluid from 3 implantation periods
(before CPB, during normothermic CPB, and during hypothermic
CPB) was analyzed.
Red blood cell volume was determined by using carbon mon-
oxide as a label5,12 just before the start of CPB. Subsequent blood
and plasma volumes were calculated from determination of the
l, serum albumin and serum total protein concentrations,
volume
ermic CPB Hypothermic CPB
in 60 min 90 min 120 min 150 min
.3) 283.7 (1.7) 283.2 (1.8) 283.4 (1.9) 283.8 (1.7)
.7) 285.3 (2.1) 285.7 (2.3) 284.9 (2.9) 286.4 (2.2)
.3)** 296.1 (1.8)#, 296.6 (1.7)#, 294.7 (1.7)§ 293.6 (1.7)‡
.8) 58 (3.8) 61 (5.0) 66 (6.5) 65 (6.4)
.0) 51 (2.9) 59 (2.3) 61 (2.9) 59 (4.0)
.5) 54 (3.5) 65 (4.0) 71 (7.6) 72 (7.3)
.5) 24 (0.6) 22 (0.5) 22 (0.5) 22 (0.5)
.9) 23 (0.9) 22 (0.9) 22 (1.0) 22 (1.2)
.1) 19 (1.2)‡ 18 (1.2) 18 (1.3) 18 (1.4)
.9)††,† 21.4 (0.7)† 18.6 (0.7)† 18.6 (0.7)† 18.4 (0.7)†
.8) 34.6 (0.6) 34.7 (0.8) 34.4 (0.8) 35.0 (0.9)
.1)† 18.1 (1.1)† 16.7 (1.0)† 16.6 (1.4)† 15.6 (1.3)†
.3)† 33.4 (1.1)† 29.7 (1.1)† 29.2 (1.1)† 28.8 (1.0)†
.1) 44.7 (1.1) 44.0 (1.0) 43.6 (1.1) 44.1 (1.1)
.8)† 28.1 (1.9)† 25.6 (1.8)† 25.6 (2.0)† 25.0 (2.1)†
.5) 81.4 (3.9) 77.9 (3.6) 76.7 (3.1) 75.1 (4.3)
.3) 116.2 (9.1) 122.9 (10.6)§ 124.9 (15.0)§ 126.6 (16.5)
.1) 74.0 (4.7) 71.6 (4.6) 70.0 (5.1) 69.4 (5.1)
.18) 0.18 (0.07) 0.84 (0.08)§§ 0.52 (0.09) 0.67 (0.08)‡‡
.07) 0.01 (0.05)§ 0.39 (0.08) 0.01 (0.04)‡ 0.16 (0.04)‡
.17)‡ 0.22 (0.10) 0.56 (0.09)¶ 0.32 (0.04) 0.38 (0.06)
.01) 0.02 (0.01) 0.17 (0.09) 0.20 (0.06)* 0.33 (0.08)*
.01) 0.01 (0.01) 0.01 (0.01) 0.02 (0.01) 0.04 (0.01)
.01) 0.02 (0.01) 0.04 (0.02) 0.07 (0.03) 0.07 (0.02)
.7) 6.8 (1.6) 13.1 (4.6) 23.5 (6.6) 17.8 (7.7)
.4) 18.1 (4.0) 15.6 (4.1) 20.1 (5.4) 28.6 (8.9)
.5) 5.3 (0.8) 8.7 (2.3) 19.3 (6.3) 16.9 (4.6)
.7) 51.1 (4.3) 58.9 (4.6) 58.8 (5.2) 58.2 (5.9)
.2) 46.4 (3.3) 53.7 (4.1) 57.4 (6.1) 57.6 (7.2)
.1) 58.8 (6.9) 70.2 (6.8) 69.6 (7.1) 72.1 (8.2)
ented as means, with SEMs in parentheses. CPB, Cardiopulmonary bypass;
h group (n  7). *P  .05 and †P  .001 compared with time 0. ‡P  .05,
mpared with values at 30 minutes. #P  .05 and **P  .01 compared with
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calculated plasma volumes were corrected according to the fol-
lowing equation to assess the real in vivo plasma volume of the
animals during CPB:
Real volume  Calculated volume – Volume in CPB circuit.
Fluid Loss and Supplementation and Fluid
Extravasation
Urine output was recorded every half hour through a suprapubic
catheter. Fluid balance (ie, fluid input and output) was recorded
continuously. After the start of CPB, fluid additions to the machine
reservoir and net fluid balance (NFB) (ie, all fluid additions and
losses, including diuresis) were calculated on a half-hour basis.
Figure 2. COP in plasma (A) and interstitial fluid (B). Values are
presented as means  SEM. Open circles, Albumin as prime;
closed circles, acetated Ringer solution as prime (CT group);
triangles, HES as prime. A, Values at start of and during CPB.
Dotted line, start of cooling. ●●●P < .001 compared with CT
group, ***P < .001 compared with initial value. B, Sampling
number: 1, before CPB; 2, after 1 hour of normothermic CPB; 3,
after 90 minutes of hypothermic CPB. ●●P < .01 compared with
CT group.The fluid extravasation rate (FER) was subsequently calculated for
290 The Journal of Thoracic and Cardiovascular Surgery ● Augueach individual experiment on a half-hour basis as the net fluid
balance corrected for changes in plasma volume (PV) per 30
minutes (PV), according to the following formula:
FER (mL/kg/30 min)  NFB (mL/kg/30 min)
 PV (mL/kg/30 min)
Albumin Mass, Protein Mass, and Albumin and
Protein Extravasation
Total intravascular albumin and protein masses (in grams within
the animal, tubing, and machine reservoir) were determined as the
product of PV (in liters within the animal, tubing, and reservoir)
and the serum albumin (ie, measured albumin mass; Figure 1) or
serum total protein concentrations in grams per liter.
In addition, we calculated the albumin mass in the Alb group as
follows:
Calculated albumin mass (g)  Albumin (g/L)  PV (L)
 Albumin added (g)/Time interval (30 min)
If the measured albumin mass was less than the calculated
albumin mass, we could conclude that albumin was lost from
circulation.
End of Experiment and TTW
At the end of each experiment, the pigs were killed with an
intravenous injection of 20 mL of saturated KCl solution.
Immediately after the animals were killed, tissue samples (3
parallel pieces) were taken simultaneously from the left quadriceps
muscle, abdominal skin, colon, ileum, stomach, liver, pancreas,
kidney, lung, and heart (left and right ventricular myocardium) and
placed in preweighed vials, reweighed, and placed in a drying
chamber at 70°C. The vials were weighed repeatedly until a stable
weight was obtained. TTW was recorded as grams per gram of dry
weight.
Statistical Methods
The results are presented as the mean and SEM. All data were
analyzed by means of the Graph Pad InStat (version 3.02; Graph
Pad Software Inc, San Diego, Calif).
Repeated-measures analysis of variance (ANOVA) with one
grouping variable was used to test the relationship of the outcome
variable at different times. If a significant between-group P value
was found, a 1-way ANOVA was applied, followed by using the
Tukey-Kramer multiple comparisons test. Furthermore, when find-
ing a significant within-group P value, a post hoc paired t test was
used. The level of significance was adjusted according to the
number of comparisons. The 1-way ANOVA was also used when
comparing the non-CPB and CT groups and in each of the inter-
ventional groups. This test was followed by the Tukey-Kramer
multiple comparisons test when necessary.
Results
All animals studied were comparable with respect to age
(CT group, 12.8  0.6; Alb group, 13.9  0.5; HES
group, 12.0  0.8; and non-CPB group, 13.5  0.4
weeks), weight (31.9  1.3, 35.3  2.1, 28.5  1.5, and
32.7  1.0 kg, respectively), and sex (male/female: 9/1,
5/2, 6/1, and 11/2, respectively). Variations in serum
st 2005
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Posmolality (Table 1) and acid-base parameters were sim-
ilar in all groups, and the values remained within normal
ranges throughout the study. The serum osmolality in the
HES group was significantly higher than in the CT and
Alb groups, as displayed in Table 1.
Hemodynamics
All animals remained cardiovascularly stable with beating
hearts during the experiments. CVP remained essentially
unchanged in all groups at a level of 7  1 mm Hg, as
measured in the femoral vein. No venous obstruction at the
site of drainage (right atrium) was present during the stud-
ies. MAP tended to increase slightly in all groups without
reaching significance (Table 1). Values for blood losses and
diuresis are given in Table 1. In the CT group a significant
increase in diuresis was seen after the start of cooling. No
such increase was observed in the interventional groups.
Albumin and Protein Concentrations, Masses, Plasma
Volume, and COPs
Initiation of CPB resulted in a 25% hemodilution in the CT
and Alb groups (P  .001) and a 40% hemodilution in the
HES group judged on the basis of the changes in Hct levels
(P  .001, Table 1). This degree of hemodilution is also
reflected by a decrease in both the serum albumin and serum
protein concentrations after the start of CPB in the CT and
HES groups (P  .001), whereas the albumin and protein
concentrations remained unchanged in the Alb group
throughout the experiments related to the prime composi-
tion (Table 1).
Plasma volume remained essentially unchanged, with no
significant within-group or between-group differences
throughout the experiments, although a slight increase could
be observed in the HES group (Table 1).
The albumin masses remained stable at about 50 g in the
CT and HES groups during the experiments (Figure 1). In
the Alb group an increase in the mass was seen immediately
after initiation of CPB (P  .05), with a slight initial
difference between the measured and calculated values
(Figure 1). After 60 minutes of CPB, the calculated and
measured values became equal. The protein mass showed a
similar pattern for the respective groups, as demonstrated in
Table 1.
COPp decreased significantly immediately after the start
of CPB in the CT group (P  .001) but remained iso-
oncotic throughout the experiments both in the Alb and
HES groups (Figure 2, A). COPi decreased slightly in the
CT group (P .05) and remained unchanged in the Alb
group, whereas a slight insignificant increase was present in
the HES group (Figure 2, B). Consequently, the changes in
the COPp-i gradients were most pronounced in the CT
group (8.1  0.8 to 2.5  0.6 mm Hg, P  .001), followed
by the HES group (7.5  0.8 to 6.0  0.3 mm Hg) and the
Alb group (9.4  0.3 to 8.3  0.6 mm Hg).
The Journal of ThoraciFluid Additions, Net Fluid Balance, and Fluid
Extravasation
Fluid additions to the CPB circuit reservoir are presented in
milliliters per kilogram per minute half hourly in Table 1.
FERs are displayed in Figure 3.
Immediately after the start of CPB, the FERs were
0.99  0.12 mL · kg1 · min1 in the CT group and 0.33 
0.11 and 0.24  0.16 mL · kg1 · min1 (P  .001
compared with the CT group at same time) in the Alb and
HES groups, respectively. The values rapidly leveled off
within 5 to 20 minutes to a new steady state. This new level
(ie, the last 30 minutes of normothermic CPB; Figure 3) was
used as baseline for all subsequent changes during induction
of hypothermic CPB.
Immediately after the start of cooling, the FER increased
significantly in the CT group (P  .01), from 0.15  0.10
to 0.64 0.12 mL · kg1 · min1, whereas no such increase
was observed in the interventional groups (Alb and HES
groups, Figure 3). In fact, in the Alb group FER was
significantly lower at 90 minutes (P .05) and 120 minutes
(P  .01) compared with that seen in the CT group. In the
HES group FER remained at about 0.3 mL · kg1 · min1
during normothermic and hypothermic CPB (Figure 3).
TTW
Table 2 displays the TTW in the different tissues and
organs. The values were compared with those of a reference
group (n  13) that never underwent bypass (the non-CPB
control group). When acetated Ringer solution was used as
prime, TTW increased in most organs compared with the
non-CPB control group (Table 2). When albumin or HES
was used as prime, the TTW was greater than that of the
Figure 3. FER during normothermic (NT-CPB) and hypothermic
CPB (HT-CPB). Values are presented as means  SEM. **P < .01
compared with NT-CPB. ●P < .05 and ●●P < .01 compared with
CT group at same time.non-CPB control group in a series of tissues and organs but
c and Cardiovascular Surgery ● Volume 130, Number 2 291
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CSPsignificantly less than the values of the CT group, in which
acetated Ringer solution was used as prime (Table 2).
Discussion
A variety of priming solutions for the extracorporeal circuit
have been proposed. Albumin is one of the most common
prime additives, although alternative colloids, such as dex-
tran, HES, and gelatins, are used. The ideal colloid is still
debated, and the controversy concerning crystalloids versus
colloids is still ongoing.
Edema formation during and after CPB is well known to
occur as a result of reduced COP in plasma. This might lead
to myocardial fluid accumulation with cardiac dysfunc-
tion,13 an increase in extravascular lung water,14 and gas-
trointestinal edema.5 Edema of the central nervous system
has also been reported.15,16 The rationale for adding colloids
to the priming solution is to boost the plasma COP and
thereby to prevent fluid leakage and edema formation.
In recent studies5-8 we presented data supporting a cold-
induced extravasation of fluid from the circulation to the
interstitial space during hypothermic CPB when acetated
Ringer solution was used as prime. The present study was
carried out to evaluate whether preservation of the plasma
oncotic pressure could prevent or reduce this temperature-
dependent fluid leakage during CPB. In brief, our hypoth-
esis was confirmed.
Prime Solutions and Fluid Extravasation
HES or albumin was used as CPB prime, as supplemental
fluid to the CPB circuit reservoir, and for blood loss sub-
TABLE 2. Total water content (gram per gram of dry w
circulation
Tissue Non-CPB (n  13)
Right myocardium 4.17 (0.02)
Left myocardium 4.00 (0.04)
Lung 4.16 (0.07)
Liver 2.89 (0.05)
Left kidney 4.48 (0.07)
Right kidney 4.56 (0.08)
Stomach (muscularis) 4.03 (0.09)
Stomach (mucosa) 4.41 (0.08)
Pancreas 3.40 (0.10)
Ileum (muscularis) 3.65 (0.18)
Ileum (mucosa) 4.72 (0.05)
Colon 3.85 (0.19)
Skeletal muscle 3.43 (0.04)
Skin 1.93 (0.07)
Brain 3.74 (0.09)
Values are presented as means  SEM and compared with a control grou
CT, control group; Alb, albumin group; HES, HES group. *P  .05, †P 
compared with control.stitution before and during bypass. Both solutions resulted
292 The Journal of Thoracic and Cardiovascular Surgery ● Auguin stable iso-oncotic pressures in plasma throughout the
experiments. Although COPp remained stable and similar in
the Alb and HES groups, fluid intravasation occurred im-
mediately after the start of CPB with HES as prime, whereas
fluid was shifted out of the circulation with albumin. One
possible explanation for the differences might be sought in
the higher serum osmolality in the HES group compared
with the 2 other groups. Consequently, the HES-induced
fluid intravasation after the start of CPB resulted in a 40%
decrease in Hct levels compared with a 25% decrease in the
CT and Alb groups, respectively. The changes in Hct levels
were not related to more pronounced bleeding in the HES
group, as indicated in Table 1.
As reported in previous studies,5-8 the start of cooling
abruptly increased the FER in the CT group. In the present
study no such increase could be observed either in the HES or
Alb group. In fact, in the Alb group FER remained less than
that of the CT group during hypothermic CPB, whereas FER
remained stable at a level in between in the HES group. To
conclude, albumin and HES reduced the cold-induced fluid
shift effectively. This is in line with other studies pointing out
reduced weight gain after CPB, when colloids are added to the
machine prime.17-20 In a meta-analysis of 17 prospective ran-
domized clinical trials,17 no differences could be demonstrated
between albumin and artificial colloids for fluid balance across
7 studies (260 patients) and oncotic pressures across 5 studies
(248 patients). In our study albumin seems to prevent fluid
extravasation more effectively than HES, despite similar COPp
values. The differences between albumin and HES are, how-
t) in different tissues after hypothermic extracorporeal
CT (n  10) Alb (n  7) HES (n  7)
4 (0.06)‡ 4.22 (0.06)¶ 4.30 (0.03)
6 (0.05)† 4.10 (0.05) 4.11 (0.08)
8 (0.31)‡ 5.00 (0.39) 4.94 (0.34)
8 (0.04)‡ 3.25 (0.07)‡ 3.24 (0.05)‡
8 (0.08) 4.47 (0.05) 4.36 (0.07)
8 (0.08) 4.43 (0.04) 4.32 (0.05)
4 (0.12)‡ 4.46 (0.06)*,§ 4.74 (0.04)†
7 (0.15) 4.30 (0.23)§ 4.38 (0.16)
3 (0.11)‡ 3.67 (0.12)*,¶ 4.02 (0.24)*
2 (0.24)† 4.34 (0.09)* 4.44 (0.17)*
3 (0.22)† 4.74 (0.06)§ 5.28 (0.23)*
5 (0.18)‡ 4.38 (0.17) 4.23 (0.18)§
8 (0.05)‡ 3.74 (0.09)†,§ 3.89 (0.12)†
5 (0.18)* 2.65 (0.09)† 2.31 (0.10)
4 (0.15) (n3) 3.89 (0.05) 3.71 (0.09)
never went through CPB (non-CPB group). CPB, Cardiopulmonary bypass;
P  .001 compared with non-CPB; §P  .05, P  .01, and ¶P  .001eigh
4.5
4.2
5.6
3.2
4.6
4.5
4.9
4.6
4.5
4.5
5.5
5.0
3.9
2.4
3.8
p that
.01, ‡ever, not significant.
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PHES, which was used in the present study, is character-
ized by its mean molecular weight of 200,000 d, with 80%
of the particles ranging from 13,000 to 780,000 d and with
a 10% bottom fraction of less than 13,000 d. It is likely that
the low-molecular-weight fraction of HES leaks from the
intravascular to the extravascular space. If so, that could
explain the slight increase in COPi throughout the experi-
ments in the HES group and also the constant FER values
seen both during normothermic and hypothermic CPB.
Finally, when comparing the changes in TTW, the use of
albumin as prime reduced tissue edema more effectively
than HES. One exception was the tendency toward lower
TTW values in the brain obtained in the HES group. This
might be related to the higher serum osmolality in this group
and requires further investigation.
Albumin Versus Artificial Colloids
A number of authors have recommended the use of artificial
colloids instead of human albumin as a cost-containment
measure. However, concerns still remain about the potential
adverse effects of artificial colloids, such as allergic-ana-
phylactic reactions, effects on hemostasis, and effects on
viscosity.
The use of HES in a CPB setting has been associated
with excessive postoperative bleeding and increased trans-
fusion requirements. Postoperative bleeding was evaluated
in a meta-analysis of 653 patients recruited from 16 studies.
In 88% of the randomized comparisons, postoperative
bleeding was lower among albumin recipients compared
with HES recipients.21 Similar results were recently pre-
sented by Kuitunen and coworkers.22
In a study by Sade and associates23 comparing crystal-
loids with colloids (albumin and HES), differences were
obtained with a substantially higher viscosity in the HES
group than in the albumin and crystalloid groups, in which
blood viscosity was nearly the same. This finding might be
of special significance during hypothermic CPB because
hypothermia per se also contributes to increased blood
viscosity.
It has been hypothesized that albumin might minimize
activation of blood platelets and the complement system
through coating of the CPB circuit.24 In addition, albumin
possesses properties like antioxidant and free radical–scav-
enging activity, binding affinity for lipids, drugs, toxic sub-
stances, and other ligands and the ability to inhibit apoptosis
in the microvascular endothelium.21,25 Thus far, albumin
therefore should theoretically be our first-choice colloid
with limited effects on viscosity and blood hemostasis and
might be, by preventing fluid leakage, more effective.
Albumin Mass
The albumin mass of the CT and HES groups remained
stable, indicating no net loss of albumin from the circulation
The Journal of Thoracithroughout the study. In the Alb group, however, an initial
increase of the albumin mass was seen after the start of
bypass related to the priming solution. The discrepancy
between the calculated and measured albumin masses indi-
cates a net albumin loss of about 20 g during the initial 30
minutes, which is half of the amount present in the prime.
One explanation could be an initial trapping of albumin at
the surfaces of the CPB circuit.26 The initial albumin loss in
our study was 10-fold of that reported26 and could also be
explained by a short-lived albumin extravasation. In human
subjects plasma volume expansion with albumin led to a
50% loss during an observation period of 3 hours.27 To what
extent the use of alien human albumin in this porcine model
influenced the transvascular shift of albumin is, to our
knowledge, unknown.
Methodologic Considerations
In the present animal study a degree of hemodilution above
that normally accepted in a clinical setting was used to
obtain significant differences in COPp in the interventional
groups compared with in the control group.
Conclusion
Preservation of COP effectively reduces the cold-induced
fluid extravasation during CPB. Albumin seems to be supe-
rior to HES in reducing tissue edema.
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